Daniela Pugliese

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

María Chaparro, A Verreth, Triana Lobatón et al. · The American Journal of Gastroenterology · 2018 · 171 citations

Medicine, Immunology, Pediatrics +16

Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti‐TNF alpha: 5‐year follow‐up study

Daniela Pugliese, Luisa Guidi, Pietro Manuel Ferraro et al. · Alimentary Pharmacology & Therapeutics · 2015 · 113 citations · Full text

Medicine, Dermatology, Pharmacotherapy +14

Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study

Alessandro Armuzzi, Carla Felice, Alfredo Papa et al. · Journal of Crohn s and Colitis · 2013 · 106 citations

Medicine, Internal Medicine, Pharmacotherapy +13

Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants

Gianluca Andrisani, Daniela Frasca, Maria Romero et al. · Journal of Crohn s and Colitis · 2012 · 92 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year

Luisa Guidi, Manuela Marzo, Gianluca Andrisani et al. · Digestive and Liver Disease · 2014 · 89 citations

Life Sciences, Immunology, Immunopathology +16